Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Is it safe to breastfeed for mothers with an infection?
Mothers who wish to breastfeed during periods of acute infections need strong support, especially during the COVID-19 pandemic, suggests a Singapore study.
Is it safe to breastfeed for mothers with an infection?
05 Oct 2022Trans fatty acid intake tied to hypertensive disorders of pregnancy
Prepregnancy intakes of total fat, unsaturated fat, and monounsaturated fatty acid (MUFA) do not appear to contribute to hypertensive disorders of pregnancy (HDP), but trans fatty acid (TFA) shows a positive association with HDP, reports a study.
Trans fatty acid intake tied to hypertensive disorders of pregnancy
05 Oct 2022Bashir catheter shows treatment potential for pulmonary embolism
Pharmacomechanical catheter-directed thrombolysis (PM-CDT) using the Bashir endovascular catheter demonstrated potential for the treatment of intermediate-risk acute pulmonary embolism (PE), findings from the RESCUE* trial have shown.
Bashir catheter shows treatment potential for pulmonary embolism
05 Oct 2022Inflammation ups risk of chemo-induced decline in frailty status in older women with breast cancer
Robust older women with early breast cancer who have high prechemotherapy levels of both interleukin-6 (IL-6) and C-reactive protein (CRP) are >3 times more likely to experience chemotherapy-induced decline in frailty status than their counterparts with low levels of these inflammatory markers, a prospective study has shown.
Inflammation ups risk of chemo-induced decline in frailty status in older women with breast cancer
05 Oct 2022Quick progression to castration resistance tied to survival in nonmetastatic CRPC
In men with nonmetastatic castration-resistant prostate cancer (M0CRPC), the prostate-specific antigen (PSA) doubling time and the time to castration resistance (TTCRPC) predict cancer-specific survival (CSS), a recent study has found.
Quick progression to castration resistance tied to survival in nonmetastatic CRPC
05 Oct 2022Niraparib maintenance boosts PFS in advanced ovarian cancer
Maintenance therapy with the PARP* inhibitor niraparib led to a sustained and durable progression-free survival (PFS), regardless of biomarker status, in patients with primary advanced ovarian cancer who responded to platinum-based chemotherapy, an updated analysis of the phase III PRIMA/ENGOT-OV26/GOG-3012 trial has shown.